Submitted by Anonymous (not verified) on 14 November 2025 - 13:36
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Date of authorisation: 30/06/2025, Revision: 1, Status: Authorised
Source: